World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01080105
Date of registration: 02/03/2010
Prospective Registration: Yes
Primary sponsor: Northwestern University
Public title: Internet Intervention for the Prevention of Depression - Approaches to Improving Mood AIM
Scientific title: Technology Assisted Behavioral Intervention for the Prevention of Depression
Date of first enrolment: June 2012
Target sample size: 0
Recruitment status: Withdrawn
URL:  http://clinicaltrials.gov/show/NCT01080105
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention  
Phase:  Phase 1
Countries of recruitment
United States
Contacts
Name:     David C. Mohr, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Northwestern University
Key inclusion & exclusion criteria

Inclusion Criteria:

- PredictD Risk Score of .130

- Has a telephone, e-mail account, computer, and broadband access to the Internet.

- Is able to speak and read English.

- Is at least 19 years of age.

- Is able to give informed consent.

Exclusion Criteria:

- Has DSM-IV diagnosis of Major Depressive Episode assessed using the MINI

- Has hearing or voice impairment that would prevent participation in psychotherapy.

- Has visual impairment that would prevent use of the workbook and completion of
assessment materials.

- Meets criteria for dementia by scoring < 25 on the Telephone Interview for Cognitive
Status (TICS).

- Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder,
current post-traumatic stress disorder (PTSD), current substance abuse, or other
diagnosis for which participation in a clinical trial of psychotherapy may be either
inappropriate or dangerous. Patients with substance abuse diagnoses who have been
clean and sober for 3 months will be admitted if otherwise eligible.

- Is currently receiving individual psychotherapy or planning to receive psychotherapy
during the 12-week treatment phase of the study.

- Is planning to be out of town or unavailable for treatment for 4 weeks or more during
the scheduled treatment time.

- Exhibits severe suicidality, including ideation, plan, and intent.

- Has initiated treatment with an antidepressant in past 10 days. Once patients have
been on a stable dose for 10 days and do not have an appointment with a physician or
psychiatrist to change this dose, the patient will be eligible based on this
criterion.



Age minimum: 19 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Individuals at Risk for Depression
Intervention(s)
Behavioral: AIM Web based intervention + surveillance
Behavioral: Educational website
Behavioral: AIM web based intervention
Primary Outcome(s)
Depression, as assessed by Quick Inventory of Depressive Symptoms (QIDS), the Patient Health Questionnaire-9 (PHQ-9), and the Mini International Neuropsychiatric Interview (MINI) Disorders-Major Depressive Disorders Module [Time Frame: Measured at baseline, week 6, week 12 and month 3, month 6, month 9 and month 12]
Website utilization (e.g., number of logins, average visit length, total time spent on the site, number of exercises completed), Attrition and cost effectiveness. [Time Frame: From baseline through 12 month follow-up]
Secondary Outcome(s)
Anxiety, impact on work, social support [Time Frame: Measured at baseline, week 6, week 12 and month 3, month 6, month 9 and month 12]
Secondary ID(s)
NU IRB STU00020637
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history